Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial
Michael R. Migden(The University of Texas MD Anderson Cancer Center), Alexander Guminski(Royal North Shore Hospital), Ralf Gutzmer(Medizinische Hochschule Hannover), Luc Dirix(GZA Ziekenhuizen Campus Sint-Augustinus), Karl D. Lewis(University of Colorado Denver), P. Combemale, R. M. Herd(Glasgow Royal Infirmary), Ragini R. Kudchadkar(Moffitt Cancer Center), Uwe Trefzer(Dermatologikum Hamburg), Sven Gogov(Novartis (Switzerland)), Céline Pallaud(Novartis (Switzerland)), Tingting Yi, Manisha Mone, Martin Kaatz(SRH Wald-Klinikum Gera), Carmen Loquai(Johannes Gutenberg University Mainz), Alexander Stratigos(Andreas Sygros Hospital), H. J. Schulze(Fachklinik Hornheide), Ruth Plummer(Freeman Hospital), Anne Lynn S. Chang(Stanford University), Frank Cornélis(Cliniques Universitaires Saint-Luc), John T. Lear(Manchester Academic Health Science Centre), Dalila Sellami(Center for Global Development), Reinhard Dummer(University Hospital of Zurich)
Cited by 427
Abstract
Related Papers
No related papers found
Powered by citation graph analysis